Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AKT1 E17K
i
Other names:
AKT1, AKT, PKB, PRKBA, RAC, V-akt murine thymoma viral oncogene homolog 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
207
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
(12)
News
Trials
Search handles
@VivekSubbiah
Search handles
@VivekSubbiah
Filter by
Latest
almost2years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation https://t.co/fl4msM7xvq (@VivekSubbiah)
almost 2 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
over2years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation @CuglievanBranko @ASCO_pubs https://t.co/FfJsdBR8oH (@VivekSubbiah)
over 2 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
almost3years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation @ASCO_pubs https://t.co/YRxeswXM5K (@VivekSubbiah)
almost 3 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
over3years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation https://t.co/U4rM5fa1Bx (@VivekSubbiah)
over 3 years ago
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
over3years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation @PanCAN @Aiims1742 @ShaalanBeg @cancerassassin1 @ASCO_pubs #JCOPO https://t.co/ELZ9Ln0lYW (@VivekSubbiah)
over 3 years ago
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
over3years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation @ASCO_pubs https://t.co/xPPZip9a3k (@VivekSubbiah)
over 3 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
over3years
ICYMI: Characteristics and outcome of AKT1 E17K–mutant #BreastCancer defined through @AACR GENIE, a clinicogenomic registry. @smythlillian @bastien_nguyen @DHymanMD @sloan_kettering #PrecisionMedicine #RealWorldData #ESMO20 https://t.co/S2rXKZtkqS (@CD_AACR)
over 3 years ago
Clinical • Real-World Evidence
|
AKT1 (V-akt murine thymoma viral oncogene homolog 1)
|
AKT1 E17K
over3years
Response to Mammalian Target of Rapamycin–Based Therapy & Incidental Finding of Lynch Syndrome in Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation @OncoAlert #oncoalert @PanCAN https://t.co/ZY8HronelR (@VivekSubbiah)
over 3 years ago
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
over3years
Response to Mammalian Target of Rapamycin–Based Therapy & Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary #PancreaticCancer With AKT1_E17K Mutation @PanCAN @ShaalanBeg @Aiims1742 https://t.co/JiVlMEciRo (@VivekSubbiah)
over 3 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
almost4years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation https://t.co/0tNmKa9N0r (@VivekSubbiah)
almost 4 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
almost4years
Response to Mammalian Target of Rapamycin–Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation https://t.co/locBOfYvsk (@VivekSubbiah)
almost 4 years ago
Clinical
|
mTOR (Mechanistic target of rapamycin kinase)
|
AKT1 E17K
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login